Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity.

Moody, Rhiane; Wilson, Kirsty L; Boer, Jennifer C; Holien, Jessica K; Flanagan, Katie L; Jaworowski, Anthony; Plebanski, Magdalena

Moody, Rhiane; Wilson, Kirsty L; Boer, Jennifer C; Holien, Jessica K; Flanagan, Katie L; Jaworowski, Anthony; Plebanski, Magdalena.

Affiliation

Moody R; School of Health and Biomedical Science, STEM College, RMIT University, Bundoora, VIC, Australia.
Wilson KL; School of Health and Biomedical Science, STEM College, RMIT University, Bundoora, VIC, Australia.
Boer JC; School of Health and Biomedical Science, STEM College, RMIT University, Bundoora, VIC, Australia.
Holien JK; School of Science, STEM College, RMIT University, Bundoora, VIC, Australia.
Flanagan KL; School of Health and Biomedical Science, STEM College, RMIT University, Bundoora, VIC, Australia.
Jaworowski A; Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, TAS, Australia.
Plebanski M; School of Medicine, University of Tasmania, Launceston, TAS, Australia.

Front Bioinform ; 1: 709533, 2021.

Article de En | MEDLINE | ID: mdl-36303764

Mots clés

COVID-19; autoimmunity; epitope mapping; molecular-mimicry; peptides; self-reactivity

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Front Bioinform Année: 2021 Type de document: Article Pays d'affiliation: Australie Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google